At Putney, we specialize in developing high-quality, generic medicines for pets. Currently, only 7% of FDA-approved pioneer brand name pet medicines have a generic equivalent.1 More than 80% of human prescriptions (what we use for ourselves and our children) are filled with generic drugs.2 We believe veterinarians and pet owners deserve the benefits of high-quality, affordable generics, too.
Same As the Brand — and More Affordable
Our veterinary-approved products are proven equivalent to the pioneer brand.
- You can expect the same efficacy and safety profile as the brand for a better price.
- Our products are manufactured in FDA-inspected facilities that are compliant with current Good Manufacturing Practices (cGMP).
- We adhere to the same rigorous standards as the brand name product.
As with brand manufacturers, our Veterinary Support team is available to support you and our products. Call us at 1-866-683-0660 to speak to one of our staff veterinarians. We are here to answer your product and case-related questions, or to provide more information about our bioequivalent products.
FDA-CVM (Center for Veterinary Medicine) Approved Veterinary Generics
Since we started in 2006, we have built a robust product pipeline for generics in animal health.
Our focus is on developing generic equivalents of expensive and frequently used veterinary drugs where cost is a barrier to prescribing, compliance or use. These include anti-infective, pain, anesthesia/sedation and dermatological drugs.
We currently offer five FDA-CVM approved products: Putney Enrofloxacin Flavored Tablets, Putney Cefpodoxime Proxetil, Putney Mupirocin Ointment 2%, Putney Carprofen Caplets, and Putney Ketamine HCl for Injection.
Please note that we also make available for sale certain FDA-approved human generic drugs through authorized distributors and to veterinary practices. Those drug products are approved by the FDA for use in humans and are not approved by the FDA for use in animals.
1 Source: Putney analysis of FDA-CVM approvals 2/2013.
2 Source: IMS Health 2011.